This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
JAMA
jama.com
did:plc:q5ogl3twkcqyhvz4zebonw3z
Among adults with CKD stage 4/5 or on dialysis, low-dose rivaroxaban did not lower cardiovascular risk but did raise major bleeding rates, supporting guideline caution in this group.
ja.ma/3TgP0Tp
2026-07-28T18:27:11.977Z